| AMT-116 in Patients with Solid Tumors (NCT06782334) | Multitude Therapeutics Inc. | 2024-05-07 |
| PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY (NCT06354140) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2024-05-07 |
| Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients (NCT06306014) | Hospices Civils de Lyon | 2024-05-07 |
| A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease (NCT06300320) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-05-07 |
| PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS (NCT06391905) | Guangdong Provincial People's Hospital | 2024-05-06 |
| A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis (NCT06457425) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2024-05-06 |
| Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section (NCT06344169) | Dalin Tzu Chi General Hospital | 2024-05-06 |
| A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus (NCT06360068) | Qiong Fu | 2024-05-06 |
| Comparison of Supra vs Infra Inguinal Fascia Iliaca Blocks for Spinal Positioning and Analgesia in Lower Limb Surgery (NCT07221682) | Sahiwal medical college sahiwal | 2024-05-06 |
| Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer (NCT06255379) | Guangzhou University of Traditional Chinese Medicine | 2024-05-06 |
| Preventing Injured Knees From osteoArthritis: Severity Outcomes (NCT06096259) | Brigham and Women's Hospital | 2024-05-06 |
| The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor (NCT06311968) | Jian Chen | 2024-05-06 |
| HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction (NCT06391710) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-05-06 |
| A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) (NCT06138639) | Solid Biosciences Inc. | 2024-05-06 |
| Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis (NCT06342466) | Jin Lu, MD | 2024-05-06 |
| QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer (NCT06404463) | Fudan University | 2024-05-06 |
| Vitiligo Treatment by Targeting TYK2 Mediated Responses (NCT06327321) | Centre Hospitalier Universitaire de Nice | 2024-05-05 |
| Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer (NCT06200103) | Mayo Clinic | 2024-05-03 |
| 177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry (NCT06395402) | University of Iowa | 2024-05-03 |
| Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma (NCT06029309) | Alvaro Alencar, MD | 2024-05-03 |
| Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases (NCT05800210) | University of Florida | 2024-05-03 |
| Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab (NCT06249048) | Strand Therapeutics Inc. | 2024-05-03 |
| RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA (NCT06146101) | Incannex Healthcare Ltd | 2024-05-02 |
| Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women (NCT05808166) | International Vaccine Institute | 2024-05-02 |
| Impact of Selenium on Methotrexate Induced Spermatotoxicity; A Comparative Study (NCT06951282) | Ain Shams University | 2024-05-02 |
| A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma (NCT05991388) | University of Birmingham | 2024-05-02 |
| A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD) (NCT06402838) | Hoffmann-La Roche | 2024-05-02 |
| Multimodal Imaging in Rectal Cancer & Pancreatic Cancer (NCT06395337) | Radboud University Medical Center | 2024-05-02 |
| European Blood Pressure Intensive Control After Stroke (NCT04647292) | University College Dublin | 2024-05-02 |
| Basket Study for Oligo-metastatic Breast Cancer (NCT05982678) | The Netherlands Cancer Institute | 2024-05-02 |
| Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation (NCT06141447) | University of Colorado, Denver | 2024-05-02 |
| The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities (NCT06593899) | Fujian Medical University Union Hospital | 2024-05-01 |
| Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study. (NCT06230146) | Assiut University | 2024-05-01 |
| Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma (NCT06552559) | Samsung Medical Center | 2024-05-01 |
| Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease (NCT06866158) | PT. JES Kasih Nusantara Sejahterah | 2024-05-01 |
| A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple Sclerosis (NCT06104683) | Loxo Oncology, Inc. | 2024-05-01 |
| HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer (NCT06389500) | Harbin Medical University | 2024-05-01 |
| Emergence Agitation of Sevoflurane in Pediatric (NCT06830564) | Ain Shams University | 2024-05-01 |
| I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers (NCT05986071) | Institut Paoli-Calmettes | 2024-05-01 |
| A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing ARDS (NCT06657079) | Damanhour University | 2024-05-01 |
| A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab VS FLOT Combined With Trastuzumab (NCT06681298) | xiaohua li | 2024-05-01 |
| Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer (NCT06319313) | Shanghai JMT-Bio Inc. | 2024-05-01 |
| De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR. (NCT06353685) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-05-01 |
| Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial (NCT06355583) | Imperial College London | 2024-05-01 |
| DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma (NCT06264388) | Ashish Shah | 2024-05-01 |
| PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC (NCT06245889) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-05-01 |
| Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy (NCT06297083) | Murdoch Childrens Research Institute | 2024-05-01 |
| Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients (NCT07073287) | Universidade Federal de Pernambuco | 2024-05-01 |
| Metabolic Changes Induced by NMN in Healthy Subjects With Acute Binge Drink (NCT05882214) | Zhejiang Chinese Medical University | 2024-05-01 |
| An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy. (NCT07282262) | Peking Union Medical College Hospital | 2024-05-01 |
| Proof-of-concept to Evaluate the Efficacy and Safety of Prednisone in Idiosyncratic Hepatotoxicity (NCT06251232) | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 2024-05-01 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) (NCT06137183) | Genentech, Inc. | 2024-05-01 |
| Effectiveness of Platelet-rich Plasma Treatment of Knee Osteoarthritis (NCT05825105) | Universidad Nacional de Entre Rios | 2024-05-01 |
| Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer (NCT06419673) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-05-01 |
| Collaborative Solutions for Breaking up Sedentary Time in Black Older Adults With Type 2 Diabetes: The Interrupt Diabetes Study (NCT06283849) | University of Minnesota | 2024-05-01 |
| Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer (NCT06368141) | Ruijin Hospital | 2024-05-01 |
| A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults (NCT06344975) | Starna Therapeutics | 2024-05-01 |
| Impact Of Metformin In Rectal Cancer Patients (NCT06728982) | Minia University | 2024-05-01 |
| Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma (NCT06426797) | Peking University People's Hospital | 2024-05-01 |
| Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer (NCT06575257) | Xijing Hospital | 2024-05-01 |
| Effect and Mechanism of Baitouweng Decoction for Large Intestine Damp-heat Syndrome of Ulcerative Colitis (NCT06421818) | The Second Hospital of Nanjing Medical University | 2024-05-01 |
| Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig) (NCT06485336) | St. Olavs Hospital | 2024-05-01 |
| BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers (NCT06383013) | Blue Blood Biotech Corp. | 2024-05-01 |
| BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation (NCT05959252) | Sydney Local Health District | 2024-05-01 |
| Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis (NCT06389422) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-05-01 |
| Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute Obstruction (NCT06394791) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-01 |
| RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer (NCT06385873) | The First Affiliated Hospital with Nanjing Medical University | 2024-05-01 |
| Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer (NCT06367088) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-05-01 |
| The Effectiveness of Intralesional Botulinum Toxin A and Triamcinolone Acetonide Injections in Keloid Treatment (NCT06814288) | Universitas Padjadjaran | 2024-05-01 |
| Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients (NCT06404697) | Ruijin Hospital | 2024-05-01 |
| Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer (NCT06405139) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-05-01 |
| Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC (NCT06397222) | Second Affiliated Hospital of Guangzhou Medical University | 2024-05-01 |
| A Study to Evaluate the Efficacy of ALMB-0168 in Solid Tumor Patients With Bone Metastatic Whose Prior Standard Treatment Have Failed (NCT06416358) | AlaMab Therapeutics (Shanghai) Inc. | 2024-05-01 |
| Personal Relevance of Psychotherapy for Asian Americans (NCT06632158) | IRIS Media Inc | 2024-05-01 |
| SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer (NCT06373133) | West China Hospital | 2024-05-01 |
| Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis (NCT06391645) | Beijing Tiantan Hospital | 2024-05-01 |
| Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer (NCT06231771) | Supergenics Life Science Sdn. Bhd. | 2024-05-01 |
| Cannabidiol and Older Adult Cannabis Users (NCT06290063) | University of Colorado, Boulder | 2024-05-01 |
| Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer (NCT06409429) | Tianjin Medical University Cancer Institute and Hospital | 2024-05-01 |
| CAR20(NAP)-T Therapy for B Cell Lymphoma (CARMA-01 Study) (NCT06002659) | Uppsala University | 2024-05-01 |
| Self-Management Program for AIS D SCI (NCT05800717) | VA Office of Research and Development | 2024-05-01 |
| Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment (NCT06789783) | University of Milan | 2024-05-01 |
| Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents (NCT05442216) | Joshua Zeidner | 2024-05-01 |
| A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer (NCT06339281) | Li Huiping | 2024-05-01 |
| Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease (NCT06350123) | AstraZeneca | 2024-05-01 |
| Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer (NCT06385548) | Vall d'Hebron Institute of Oncology | 2024-05-01 |
| Prophylactic Treatment With Atorvastatin for Episodic Migraine. (NCT06248671) | St. Olavs Hospital | 2024-05-01 |
| Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer (NCT06395844) | Anhui Provincial Cancer Hospital | 2024-05-01 |
| A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer (NCT06363552) | Tianshu Liu | 2024-05-01 |
| The Efficacy and Safety of Diluted Oral Phosphate Enema Versus Intravenous Sodium Glycerophosphate in The Treatment of Hypophosphatemia in ICU Patients (NCT06651892) | Ain Shams University | 2024-05-01 |
| Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor (NCT06200233) | Samsung Medical Center | 2024-05-01 |
| DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCC (NCT06397235) | Second Affiliated Hospital of Guangzhou Medical University | 2024-05-01 |
| Fruquintinib Plus Camrelizumab and HAIC in the Treatment of Non-MSI-H Advanced Colorectal Cancer (NCT06423937) | Fudan University | 2024-05-01 |
| Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma (NCT06331845) | Fujian Cancer Hospital | 2024-05-01 |
| Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease (NCT05578443) | Fujian Medical University Union Hospital | 2024-05-01 |
| Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer (NCT06403878) | Sichuan University | 2024-05-01 |
| Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder (NCT06279286) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2024-05-01 |
| N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy (NCT07279610) | The First Affiliated Hospital of Soochow University | 2024-05-01 |
| Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study (NCT06390982) | Fudan University | 2024-05-01 |
| Study of Imdusiran (AB-729) in Combination With Intermittent Dosing of Durvalumab in Subjects With Chronic HBV Infection (NCT06245291) | Arbutus Biopharma Corporation | 2024-05-01 |